Skip to main content
Equibles

SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC

Position in MGNX — Macrogenics Inc

CIK 1446179 BALA CYNWYD, PA
Back to MGNX Full portfolio

Position in MGNX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$138,142
-$3,183 QoQ
Shares Held
29,901
-73.1% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#73
of 122 holders
Holding Since
Dec 2022
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MGNX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC holds $22,485,190 across 43 Biotechnology names. MGNX ranks #34 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BMRN
Biomarin Pharmaceutical Inc
 91,886 $5,257,716
2 TWST
Twist Bioscience Corp
 34,189 $3,517,364
3 NKTR
Nektar Therapeutics
 20,177 $1,408,556
4 QURE
uniQure N.V.
 15,042 $692,834
5 OLMA
Olema Pharmaceuticals, Inc.
 55,121 $689,563
6 VKTX
Viking Therapeutics, Inc.
 16,620 $648,346
7 NTLA
Intellia Therapeutics, Inc.
 37,663 $637,257
8 HRMY
Harmony Biosciences Holdings, Inc.
 17,322 $630,694

All Filings in MGNX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $138,142 29,901
2025-03-31 $141,325 111,280
2024-12-31 $289,685 89,134
2024-06-30 $552,483 129,996
2024-03-31 $1,557,184 105,787
2023-12-31 $145,916 15,168
2023-09-30 $244,165 52,396
2023-06-30 $280,318 52,396
2023-03-31 $375,679 52,396
2022-12-31 $385,140 57,398